Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2008
11/27/2008WO2008144473A2 Chimeric pufa polyketide synthase systems and uses thereof
11/27/2008WO2008144423A2 Compositions comprising a gpr109 ligand for treating disorders of the digestive tract and/or cancer
11/27/2008WO2008144072A1 Dose forms comprising vx- 950 and their dosage regimen
11/27/2008WO2008143916A2 Prokinetic agent for bowel preparation
11/27/2008WO2008143545A1 Agent for stimulating lymphatic drainage
11/27/2008WO2008143527A1 Probiotic bacterium
11/27/2008WO2008143263A1 1-substituted tetrahydroisoquinoline compound
11/27/2008WO2008143255A1 Method for production of cell population
11/27/2008WO2008143240A1 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation
11/27/2008WO2008142859A1 Novel spiro-oxindole compound and pharmaceutical containing the same
11/27/2008WO2008142445A1 Process for the preparation of form a of tegaserod
11/27/2008WO2008141989A1 Probiotics in a pre- and/or post surgical environment
11/27/2008WO2008141368A1 Combination laxative compositions comprising a colonic stimulant and a bulking laxative
11/27/2008WO2008046087A3 Spiro compounds and their uses as therapeutic agents
11/27/2008US20080293962 Novel compounds of the N-acylamino amide family compositions comprising them and uses thereof
11/27/2008US20080293818 Regulator of Physiological Function of Ghrelin and Use Thereof
11/27/2008US20080293799 Liver Function Ameliorant
11/27/2008US20080293797 Central nervous system disorders; respiratory system disorders; sexual or reproductive disorders; eating disorders; antidiabetic agents; cardiovascular disorders; anticancer agents
11/27/2008US20080293794 Diaryltriazolmethylamine derivatives, preparation and therapeutic use thereof
11/27/2008US20080293785 Substituted benzothiazole kinase inhibitors
11/27/2008US20080293773 Amorphous Esomeprazole Hydrate
11/27/2008US20080293772 Salts of picotamide
11/27/2008US20080293767 1-Isopropyl-2-Oxo-1,2-Dihydropyridine-3-Carboxamide Derivatives Having 5-Ht4 Receptor Agonistic Activity
11/27/2008US20080293762 Preventive and Therapeutic medicament for gastroesophageal reflux disease
11/27/2008US20080293748 Thioxanthine Derivatives as Myeloperoxidase Inhibitors
11/27/2008US20080293717 Aryl sulfonamides
11/27/2008US20080293670 Edible tremella polysaccharide for prevention and/or improvement of intestinal disorder
11/27/2008US20080293667 Lipid analogs for combating tumors
11/27/2008US20080293658 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells
11/27/2008US20080293657 Modulation of the expression of stat-1-dependent genes
11/27/2008US20080293650 Fused Heterocyclic Compounds and Use Thereof
11/27/2008US20080293634 C-met receptor regulation by angiotensin iv (at4) receptor ligands
11/27/2008US20080293632 Use of natriuretic peptides for the treatment of stature disorders related to shox gene
11/27/2008US20080292733 Antioxidant and Fe2+ Chelating Properties of Herbal Extracts
11/27/2008US20080292701 Lansoprazole dosage forms; fast disintegration in the oral cavity even without water
11/27/2008US20080292693 Composition and method for treating digestive system disorders
11/27/2008US20080292661 Use of Botulinum Toxin for the Preparation of a Medicament for the Treatment of Lithiasis of Salivary Gland, Gall Bladder, Kidney, or Pancreas
11/27/2008US20080292642 Crystalline anti-human IL-12 antibodies
11/27/2008US20080292610 Medicaments containing enzymes from ciliates for promoting digestion in digestive disorders
11/27/2008US20080292604 Canine probiotic lactobacilli
11/27/2008US20080292581 Interleukin-11 Fusion Proteins
11/27/2008US20080292544 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/27/2008CA2687958A1 1-substituted tetrahydroisoquinoline compound
11/27/2008CA2687558A1 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation
11/27/2008CA2687545A1 Agent for stimulating lymphatic drainage
11/27/2008CA2687523A1 Chimeric pufa polyketide synthase systems and uses thereof
11/27/2008CA2687209A1 Process for the preparation of form a of tegaserod
11/27/2008CA2686976A1 Probiotics in a pre- and/or post-surgical environment
11/27/2008CA2686686A1 Il-9 in fibrotic and inflammatory disease
11/27/2008CA2685826A1 Prokinetic agent for bowel preparation
11/27/2008CA2684150A1 Induction of a physiological dispersion response in bacterial cells in a biofilm
11/26/2008EP1994940A1 Therapeutic use of a recombinant erythropoietin having high activity and reduced side effects
11/26/2008EP1993544A1 The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain
11/26/2008EP1993525A1 The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain
11/26/2008EP1993376A1 Animal food composition comprising nut shell
11/26/2008EP1496914B1 (20S)-1alpha-HYDROXY-2alpha-METHYL AND 2beta-METHYL-19-NOR-VITAMIN D3 AND THEIR USES
11/26/2008EP1438296B1 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
11/26/2008EP1414455B1 Isoquinoline inhibitors of p38
11/26/2008EP1370228B1 Systems for delivering a cosmetic and/or therapeutic active to oral surfaces
11/26/2008EP1153609B1 Amino acid-containing albumin preparations
11/26/2008CN101312967A Carbamate compounds as 5-ht4 receptor agonists
11/26/2008CN101312953A Pharmacologically active compounds containing sulfur
11/26/2008CN101312736A Encapsulation system
11/26/2008CN101311173A Herpe-lactone, preparation method and use thereof
11/26/2008CN101310768A Medicine composition for treating hepatic disease and use thereof
11/26/2008CN101310761A Composition for warming the middle energizer and regulating the stomach, preparation method and quality control method thereof
11/26/2008CN101310749A Chinese patent medicines for treating bellyache and gastrosis
11/26/2008CN101310743A Chinese patent medicines for treating gastrotympanites
11/26/2008CN101310723A Use of compounds that are effective as selective opiate receptor modulators
11/26/2008CN100436578C Modulation of the transcription of pro-inflammatory gene products
11/26/2008CN100436477C Cyclic peptide containing arginine, glycine, asparagicacid-sequence and active target liposome
11/26/2008CN100436453C Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
11/26/2008CN100436439C Dimeric isoflavones
11/26/2008CN100436415C Process for the preparation of (R)-& alpha, -(2,3-dimethoxyp-henyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
11/26/2008CN100436414C Azabicyclo derivatives as muscarinic receptor antagonists
11/26/2008CN100435830C Medicine for treating diarrhoea caused by weakness and cold of spleen and stomach
11/26/2008CN100435818C Medicine for treating bone ulcer
11/26/2008CN100435809C Ginseng bupleurum drop pill for treating liver disease and its preparation method
11/26/2008CN100435807C Pharmaceutical gel composition
11/26/2008CN100435806C Anionic polymers as toxin binders and antibacterial agents
11/26/2008CN100435795C Micro-powder dom peridone maleate medicinal composition and its preparing method
11/26/2008CN100435791C Solid bicyclic alcohol dispersion
11/26/2008CN100435790C EGCG-zinc complex solid dispersion, its preparation method and application
11/26/2008CN100435785C Methods and compounds for inhibiting amyloid deposits
11/26/2008CN100435663C Health-care food with functions of improving immunocompetence and protecting damaged gastric mucosa and its preparing method
11/25/2008US7456253 Growth hormone releasing peptides
11/25/2008US7456217 Administering N-(2,6-Dichlorobenzoyl)-4-(2,6-dimethoxy-4-methoxymethylphenyl)-L-phenylalanine ethyl ester for therapy of multiple sclerosis
11/25/2008US7456182 Phenylpiperazines
11/25/2008US7456158 4-dedimethylaminotetracycline derivatives
11/25/2008US7456157 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus
11/25/2008US7456155 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
11/25/2008US7455839 Method of inhibiting the formation of inhibin/betaglycan complexes with an anti-betaglycan antibody
11/25/2008US7455835 Administering soluble cytotoxic t-lymphocyte associated antigen (ctla4) molecule that binds a cell surface B7 molecule
11/25/2008CA2433878C Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
11/25/2008CA2376791C Drug delivery device for insertion in the vagina, rectum or nasal cavity
11/25/2008CA2367666C Method of treating eating disorders
11/25/2008CA2362211C Benzamide derivatives and medicament containing the same
11/25/2008CA2306508C Production of a directly compressible tabletting aid
11/25/2008CA2224369C Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use